Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

131 results about "Smallest blood vessel" patented technology

Quick Answer. The smallest blood vessels in the human body are capillaries, which connect arteries and veins. Capillaries can be as small as 5 micrometers wide.

Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders

InactiveUS7691121B2Prevent and minimize severityEasy extractionStentsDilatorsThrombosis embolismThromboembolic disorder
Embolectomy catheters, rapid exchange microcatheters, systems and methods for removing clots or other obstructive matter (e.g., thrombus, thromboemboli, embolic fragments of atherosclerotic plaque, foreign objects, etc.) from blood vessels. This invention is particularly useable for percutaneous removal of thromboemboli or other obstructive matter from small blood vessels of the brain, during an evolving stroke or period of cerebral ischemia. In some embodiments, the embolectomy catheters of this invention are advanceable with or over a guidewire which has been pre-inserted through or around the clot. Also, in some embodiments, the embolectomy catheters include clot removal devices which are deployable from the catheter after the catheter has been advanced at least partially through the clot. The clot removal device may included a deployable wire nest that is designed to prevent a blood clot from passing therethrough. The delivery catheter may include telescoping inner and outer tubes, with the clot removal device being radially constrained by the outer tube. Retraction of the outer tube removes the constraint on the clot removal device and permits it to expand to its deployed configuration. An infusion guidewire is particularly useful in conjunction with the embolectomy catheter, and permits infusion of medicaments or visualization fluids distal to the clot.
Owner:MICROVENTION INC

Preventing and/or treating cardiovascular disease and/or associated heart failure

Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of the heart muscle (for example, cardiomyopathy or myocarditis) such as idiopathic cardiomyopathy, metabolic cardiomyopathy which includes diabetic cardiomyopathy, alcoholic cardiomyopathy, drug-induced cardiomyopathy, ischemic cardiomyopathy, and hypertensive cardiomyopathy, (ii) atheromatous disorders of the major blood vessels (macrovascular disease) such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the femoral arteries, and the popliteal arteries, (iii) toxic, drug-induced, and metabolic (including hypertensive and/or diabetic disorders of small blood vessels (microvascular disease) such as the retinal arterioles, the glomerular arterioles, the vasa nervorum, cardiac arterioles, and associated capillary beds of the eye, the kidney, the heart, and the central and peripheral nervous systems, (iv) plaque rupture of atheromatous lesions of major blood vessels such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the fermoral arteries and the popliteal arteries, (v) diabetes or the complications of diabetes.
Owner:PHILERA NEW ZEALAND +1

Retinal fundus vessel segmentation method based on deep multi-scale attention convolutional neural network

The invention provides a retinal fundus vessel segmentation method based on a deep multi-scale attention convolutional neural network. An internationally disclosed retinal fundus vessel data set DRIVEis adopted to perform validity verification: firstly, dividing the retinal fundus vessel data set DRIVE into a training set and a test set, and adjusting the picture size to 512*512 pixels; then, enabling the training set to be subjected to four random preprocessing links to achieve a data enhancement effect; designing a model structure of the deep multi-scale attention convolutional neural network, and inputting the processed training set into the model for training; and finally, inputting the test set into the trained network, and testing the model performance. The main innovation point ofthe method is that a double attention module is designed, so that the whole model pays more attention to segmentation of small blood vessels; and a multi-scale feature fusion module is designed, so that the global feature extraction capability of the whole model on the segmented image is stronger. The segmentation accuracy of the model on a DRIVE data set is 96.87%, the sensitivity is 79.45%, thespecificity is 98.57, and the method is superior to classical UNet and an existing most advanced segmentation method.
Owner:BEIHANG UNIV

Method for preparing aqueous gel/nano hydroxyapatite composite scaffold for hard tissue repair

The invention belongs to the field of bio-medicinal material science, and particularly relates to a method for preparing an aqueous gel/nano hydroxyapatite composite scaffold for hard tissue repair. The method comprises the following steps of: preparing a small blood vessel by an electrostatic spinning method; preparing a degradable three-dimensional scaffold material taking the small blood vessel as a reserved passage inner wall by using a hot pressing/salting-out method; injecting injectable super-molecular aqueous gel prepared from cyclodextrin, tri-block polymer and nano hydroxyapatite into the reserved passage; and soaking the obtained scaffold into growth factor culture liquid for modification. The composition, property and shape of the prepared scaffold material are more suitable for bone surface blood vessel formation, and new cells and nutrients can enter the inner side of the scaffold through the aqueous gel in the reserved passage to induce bone growth so as to better finish the repair of bone defects. The bone repair effect of the scaffold material is obviously improved compared with other bone repair materials, and the mechanical property, blood vessel function and bone repair function of the scaffold material are obvious compared with common bone repair materials.
Owner:TONGJI UNIV

Retinal vessel image segmentation method based on improved UNet + +

The invention relates to a retinal vessel image segmentation method based on improved UNet + +, and belongs to the technical field of medical image processing. According to the method, a deep supervision network UNet + + is selected as an image segmentation network model, so that the use efficiency of features is improved; a MultiRes feature extraction module is introduced to improve the feature learning effect of small blood vessels in a low-contrast environment, the generalization ability of a network and the expression ability of a network structure are further improved by coordinating features learned by an image in different scales, and a SeNet channel attention module is added to perform extrusion and excitation operation after feature extraction to improve the accuracy of feature extraction of the small blood vessels in the low-contrast environment. Therefore, the receptive field in the feature extraction stage is enhanced, and the weight of a target related feature channel is improved. The improved UNet + + network model is verified based on a DRIVE retina image data set, and compared with an existing model, the evaluation indexes such as the overlapping ratio, the cross-parallel ratio, the accuracy and the sensitivity are improved to a certain extent.
Owner:KUNMING UNIV OF SCI & TECH

Preventing and/or treating cardiovascular disease and/or associated heart failure

InactiveUS20060009534A1Lower Level RequirementsBiocideSenses disorderZona glomerulosaIliac artery
Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of the heart muscle (for example, cardiomyopathy or myocarditis) such as idiopathic cardiomyopathy, metabolic cardiomyopathy which includes diabetic cardiomyopathy, alcoholic cardiomyopathy, drug-induced cardiomyopathy, ischemic cardiomyopathy, and hypertensive cardiomyopathy, (ii) atheromatous disorders of the major blood vessels (macrovascular disease) such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the femoral arteries, and the popliteal arteries, (iii) toxic, drug-induced, and metabolic (including hypertensive and / or diabetic disorders of small blood vessels (microvascular disease) such as the retinal arterioles, the glomerular arterioles, the vasa nervorum, cardiac arterioles, and associated capillary beds of the eye, the kidney, the heart, and the central and peripheral nervous systems, (iv) plaque rupture of atheromatous lesions of major blood vessels such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the fermoral arteries and the popliteal arteries, (v) diabetes or the complications of diabetes.
Owner:PHILERA NEW ZEALAND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products